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Yale Medicine Magazine strives to 
cover the abundance of super-
lative work being done at the 
cutting edge of various fields. It 
relies on the willing participa-
tion of students, faculty, staff, 
and alumni. It pulls in thoughts 
and advice from medical writ-
ers and communicators, past 
magazine editors, scientists, 
leadership, and many others. 
Ultimately, a consensus about 
which stories to explore, and 
which to run, coalesces around 
the framework of an idea  
or theme. 
The magazine is an exten-
sion of the school—how YSM 
talks and thinks about itself. 
Unsurprisingly, many of the 
issues and stories describe 
scientific work that is done on 
the campus, as well as the edu-
cation that enables that work. 
Sometimes, as with the issue 
celebrating 100 years of women 
in medicine at Yale in Spring 
2018, it becomes important 
to take a step back and evalu-
ate the context in which the 
school’s work happens.
This is why this issue is 
dedicated to the scientific and 
social concept of balance and 
representation: the various ways 
in which life is heterogeneous 
and prolifically varied. When the 
school reflects the multitudi-
nous world of which it is a part, it 
becomes more complete; more 
effective, more resilient.
Not every relevant story will 
make it into print. One story 
about a student testifying 
before Congress thanks to a 
powerful Washington Post Op-Ed 
won’t have happened by the 
time we go to press. Another, 
describing an exciting initia-
tive that seeks to understand 
and address inequities faced by 
those with disabilities in athlet-
ics, the Sports Equity Lab, is still 
on the drawing board. There are 
more stories about our cultural 
and intellectual diversity than 
we have space to print; this 
issue represents the very tip of 
the iceberg.
Adrian Bonenberger 
Editor, Yale Medicine Magazine
note
As we transition to new mailing 
list software, we welcome  
any changes of name, address, or 
status at ymm@yale.edu.
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  Balancing  
 Yale School of Medicine
robert alpern is proud of the progress Yale School of Medicine (YSM) has 
made in diversifying both the types of science and research pursued in New Haven, 
and the people pursuing that science and research. Diversity is central to the mission 
of scientific excellence and leadership at YSM, from diverse socioeconomic back-
grounds to variety in intellectual and academic pursuits, to variation when  
it comes to race, gender, creed, and nationality, YSM strives to be a national leader.  
Yale Medicine Magazine sat down with Robert J. Alpern, MD, dean and Ensign 
Professor of Medicine, to hear his thoughts on the subject, as well as why he favors  
a strong commitment to ongoing diversification.
Given that Yale is one of the oldest and best medical schools in the United States, how has diversity played 
a role in maintaining YSM’s competitive edge? Diversity in medicine and in biomedical research is criti-
cal to both fields. A diverse scientific and medical workforce understands and appreciates the needs 
of a diverse patient population. In addition, patients frequently prefer physicians who are similar to 
them, and thus understand their issues. We serve a broad range of patients and require the medical 
and personal expertise needed to do so effectively.
How do we stack up against peer institutions in this department? Yale strives to be a leader, and we’ve 
put significant effort into creating a diverse faculty, but we still have a long way to go. The diversity 
of our faculty is increasing, but similar to other institutions, the higher you go in academic rank, the 
less diversity there is.
Is there an active push to diversify the faculty and administrative leadership, or has the recent diversification 
been the consequence of more qualified applicants—the pipeline beginning to deliver on its promise? There 
has been a dedicated effort to identify and recruit outstanding faculty and administrative leadership 
who also bring diversity to the medical school. The last two department chair hires, both of whom 
are women, have been exceptional physicians and leaders; and the incoming dean, the first woman 
at the School of Medicine to hold this position, is incredibly impressive. That still leaves us with 80% 
of department chairs who are fairly homogeneous in the way that they have been traditionally. Even 
today, women who want careers in medicine face more barriers in their careers as they move up the 
ladder to become professors or department chairs. The pipeline is producing outstanding women and 
minority faculty, but we need to be diligent in our efforts to identify them and develop their careers. 
We’re living at a time when we are beginning to make progress.
It seems like every year, incoming classes of students are more diverse: economically, culturally, geo-
graphically, racially, and religiously. How has this changed since you were a medical student? When 
I was a medical student there was some, but very little diversity in the medical school classes. 
Women and underrepresented minorities were admitted to medical school but were few in num-
ber. Gender diversity has now been achieved with most medical school classes close to 50% women. 
Underrepresented minorities remain underrepresented, but the numbers have improved. There 




   Starting 2020  
 with an historic first 
yale school of medicine is getting a new dean, and 
for the first time in its 209-year history, she will be a 
woman. Nancy J. Brown, MD, a graduate of Yale College 
(where she majored in molecular biophysics & biochem-
istry) in the Class of 1981, comes to YSM from Vanderbilt 
University. There, she is the Hugh Jackson Morgan 
Professor and chair of the Department of Medicine. She is 
expected to join Yale on February 1, 2020.
The latest in a long and storied 
line of deans, Brown comes 
to the position as successor to 
Robert J. Alpern, MD, dean and 
Ensign Professor of Medicine, 
having already established a 
standout reputation as an inves-
tigator, clinician, and leader.
“I am grateful to the search 
advisory committee and President 
Salovey for this opportunity,” said 
Brown. “Dean Alpern has already 
been very generous in ensuring 
a smooth transition. I very much 
look forward to meeting with 
and learning from the members 
of YSM and the broader Yale and 
New Haven communities as we 
chart our course.”
Alpern was enthusiastic 
about the incoming dean, and 
the future of YSM. “Dr. Brown 
has a record of outstanding 
academic accomplishments 
and leadership. I am confident 
that she will have great suc-
cess in furthering our efforts 
in research, education, patient 
care, and creating a diverse and 
inclusive environment.” 
The universal enthusiasm 
on social media was clear as 
colleagues and past trainees 
chimed in with dozens of notes  
of congratulations, noting  
that Brown is also respected  
as an inclusive and inspiring  
mentor and colleague. From  
the outpouring of responses  
on Facebook, LinkedIn, and 
Twitter, the following testimo-
nials stood out:
“While we will miss her 
extraordinary contributions, I 
am excited for Nancy to assume 
this leadership role and wish 
her the very best on this excit-
ing new stage in her career,” 
tweeted Jeff Balser, MD, PhD, 
dean of Vanderbilt University’s 
medical school.
“Congratulations to Nancy, 
who taught me a huge fraction of 
what I know about clinical inves-
tigation & about hypertension,” 
tweeted J. Brian Byrd, MD, MS, 
from the University of Michigan.
“I have personally witnessed 
Dr. Brown’s personal, deep, and 
unwavering commitment to 
trainees of all levels as a [member 
of Vanderbilt University’s medi-
cal community]. I will be for-
ever grateful for her leadership, 
mentoring, and kindness. [YSM] 
is very lucky!” tweeted Brian 
Grieb, MD, PhD, chief resident 
at Vanderbilt University Medical 
Center’s Internal Medicine.
After finishing her stud-
ies at Yale, Brown graduated 
from Harvard Medical School, 
completed an internship and a 
residency program at Vanderbilt 
University, and has been a part 
of its faculty ever since.
Brown’s specialty and 
interests revolve around car-
diovascular pharmacology, 
pharmacogenomics, and using 
drugs to understand patho-
physiology. She has led National 
ymm.yale.edu4
chronicle
Graduate School of Arts and 
Sciences, who said of the com-
mittee’s work: “In 14 listening 
sessions and numerous informal 
meetings, they carefully col-
lected feedback, suggestions, 
and viewpoints about the cur-
rent state and future of the 
school.” President Salovey also 
expressed gratitude for Alpern’s 
longtime service and successful 
efforts to strengthen Yale School 




A legacy of leadership  
in hepatology
Among the many reasons the 
VA Connecticut Healthcare 
System in West Haven is 
regarded as one of the best in 
the country is its expertise in 
treating liver disease. This legacy 
extends back over decades and 
is the result of many illustri-
ous physicians and researchers 
building on the work of their 
predecessors. These same indi-
viduals are recognized for hav-
ing played a role in developing 
Yale School of Medicine’s reputa-
tion as a leader in the field.
Guadalupe Garcia-Tsao, MD, 
chief of digestive diseases at 
the VA Connecticut Healthcare 
System; professor of medicine 
(digestive diseases); and director 
of the Clinical and Translational 
Core of the Yale Liver Center, 
highlights one aspect of the VA 
CT’s success: the superlative 
doctors and the longstanding 
reciprocal relationship between 
the Yale School of Medicine and 
the VA. Another is the strong 
history of liver research. “From 
Gerald Klatskin, MD—a vet-
eran himself—to Harold Conn, 
MD, and Roberto Groszmann, 
MD, there has been a legacy of 
excellence here at the VA,” said 
Garcia-Tsao.
Klatskin performed the 
first liver biopsy at Yale in 1947. 
Conn’s studies resulted in the 
West Haven Criteria, a glob-
ally adopted grading system for 
hepatic encephalopathy (altered 
level of consciousness resulting 
from liver failure). Groszmann 
focused on cirrhosis and portal 
hypertension. Each researcher’s 
Institutes of Health (NIH)-
funded research since 1993 
and has defined the molecular 
mechanisms by which drugs 
for blood pressure and diabetes 
affect kidney or cardiovascu-
lar disease. Brown commented 
that the strength of discovery 
and science at Yale, as well as 
the opportunity to collabo-
rate across campus, was one of 
the attractions that led to her 
return. Meanwhile, she remains 
dedicated to providing care for 
patients with resistant and sec-
ondary forms of hypertension.
The positive and immediate 
public testimonials on Brown’s 
behalf speak to another of her 
passions: helping faculty, stu-
dents, and trainees flourish in a 
diverse and balanced work envi-
ronment. Her sterling leadership 
of Vanderbilt’s Department of 
Medicine, which began in 2010, 
corresponded with increases in 
women and underrepresented 
groups in medicine in faculty 
and other positions of authority. 
The team of doctors, staff, and 
students assembled by Brown 
has been remarkably effective. 
Research funding was boosted 
by 56%, including a 47% boost 
in grant funding from NIH. 
Citations increased, and people 
working in her department were 
more likely to be recognized by 
national professional medical 
organizations and associations. 
Brown was recommended 
to Yale University President 
Peter Salovey, PhD, by a search 
advisory committee chaired by 
Lynn Cooley, PhD, dean of the 
The incoming dean of 
Yale School of Medicine, 
Nancy Brown, MD, car-
ries with her a strong 




Kathryn Nagel, MD, 
has been using her 
expertise and experi-
ence as a Yale School 
of Medicine resident 
with type 1 diabetes  
to advocate for im-
proved accessibility  
to insulin.
For more on insulin, visit 
ymm.yale.edu/insulin
the service,” he said. It was good 
that he came when he did; he 
was diagnosed with end-stage 
liver disease in 2011. “They 
told me in March of 2012 that it 
was over if I didn’t get a trans-
plant, ‘say goodbye.’ ” Cochrane 
said. “Once I said I was onboard 
with receiving a transplant and 
doing everything I needed to 
to make that happen, includ-
ing getting 100% sober, Dr. 
Taddei moved heaven and earth 
for me.” Cochrane received a 
transplant at the Mayo Clinic 
in Jacksonville, Florida, in 2014. 
Taddei “fought to get me listed 
for a transplant,” Cochrane said, 
“I owe her my life.” 
Some wish to discontinue 
government funding for vet-
erans’ health care under the 
assumption that private health 
care will better serve this popu-
lation. Taddei is unreservedly set 
against privatization initiatives 
targeting the VA. Apart from 
the longer waits for “care in 
the community”—two to three 
months, as opposed to 14–30 
days in the VA—Taddei thinks 
that providers who spend their 
careers working with veterans 
come to know more about effi-
cient health care delivery for 
work overlapped and assisted 
with those of the others. Garcia-
Tsao led the VA CT Hepatitis C 
Resource Center, one of four 
centers nationally funded for 
over 10 years for the treatment 
and research of hepatitis C. 
During this time, VA CT devel-
oped an enduring reputation 
for excellence in liver education, 
research, and innovations in 
health care delivery. 
James Boyer, MD, Ensign 
Professor of Medicine (digestive 
diseases), who founded the Yale 
Liver Center in 1984 after his 
mentor Klatskin retired, noted 
that liver research at YSM and 
the VA were for many years 
inextricably intertwined. “For 
many years, Dr. Klatskin would 
give a talk every week at the 
VA. It was where he’d buy the 
Edgeworth tobacco he’d smoke 
in his pipe, at the commissary,” 
said Boyer. “Klatskin’s efforts 
here and in West Haven laid the 
groundwork, along with Conn 
and Groszmann, for the work 
we do today.”
Boyer remembers Klatskin 
with great respect, and wrote a 
compelling tribute to the man 
who hired him into his labora-
tory—a speech published by the 
American Gastroenterological 
Association in the December 1983 
issue of Gastroenterology on the 
occasion of Klatskin’s receipt of 
the Julius Friedenwald Medal.
That great legacy is carried on 
by current faculty appointed pri-
marily or exclusively to the VA. 
Garcia-Tsao, who spends much 
of her time tending to patients, 
has many positive things to say 
about them as individuals and 
as a population. “Veterans are 
incredibly generous as patients 
and as research subjects,” said 
Garcia-Tsao. “They are used to 
service, and when offered oppor-
tunities to participate in research, 
veterans are almost always 
excited to help.”
Doctors enjoy the sense of 
purpose derived from caring for 
veterans and from the benefits of 
a nationwide health care system 
focused entirely on caring for 
this population. “The patients 
here are extraordinary, and it’s  
a privilege to work for them,” 
said Tamar Taddei, MD, associ-
ate professor of medicine (diges-
tive diseases).
One patient of Taddei’s, 
James Cochrane, credits her 
with saving his life. Discharged 
from the Navy in 1974 after a 
three-year stint, he waited until 
2010 to seek treatment. “A lot of 
guys don’t think about the VA 
when they’re getting out. All 
they want to do is move on from 
Liver research at Yale 
was brought into the 
modern era with a suc-
cessful biopsy by Gerald 
















knowledge and connect like-
minded scientists and doctors to 
one another while simultaneously 
combatting misinformation.
Naftali Kaminski, MD, the  
Boehringer Ingelheim Pharma-
ceuticals, Inc. Professor of Medicine 
(pulmonary), (@KaminskiMed)  
got into social media early, and 
is a big believer in its utility. 
“I’m usually an early adopter,”  
he wrote via email, “I use 
Twitter for medicine, research, 
and activism. I use Facebook  
»
Social media use at  
Yale School of Medicine
Social media has revolutionized 
the way people communicate 
and share information. The 
information bottlenecks of old 
print and broadcast media have 
closed or had their influence 
diminished, for better and for 
this population than private-
sector practitioners.
“Take hepatitis C,” Taddei 
said. “The incidence of this 
in the general population is 
1.4%. But it’s as high as 12–20% 
among veterans born between 
1945–65, especially those who 
served in Vietnam. The odds 
are pretty slim of receiving bet-
ter treatment anywhere else 
than you can find here.” Recent 
efforts to cure all veterans with 
hepatitis C infection have met 
with success, according to an 
article posted on Military.com 
by Patricia Kime on June 4, 2019. 
Nearly 100,000 of the 126,000 
veterans infected with hepati-
tis C have been cured to date.
Despite the great success in 
curing hepatitis C, the preva-
lence of cirrhosis is increasing in 
the VA, and VA CT is focused on 
improving care of patients with 
advanced liver disease. Patients 
who suffer from cirrhosis are 
at high risk of developing liver 
cancer. VA CT is a regional cen-
ter for liver cancer care, har-
nessing telehealth technology to 
manage patients diagnosed with 
hepatic cancer through a weekly 
multidisciplinary liver tumor 
board attended by providers 
in Connecticut, Massachusetts, 
Vermont, and Rhode Island.
“West Haven is great,” said 
Cochrane. “Everyone there has 
looked out for me from day one, 
and I still see Dr. Taddei and her 
team once every three months. 
It’s a wonderful place. I don’t 
know where I’d be without it.”
—Adrian Bonenberger
Some YSM scientists and 
physicians are very active 
on social media, using 
it to highlight their own 
research and work, and 
that of others. In spite 
of its rough reputation, 
Twitter has a surprisingly 
robust and respectful 
medical and scientific 
community that actively 
shares information.
worse, while a world of exper-
tise and information lies at the 
fingertips of individuals. The 
new world is filled with people 
connecting with each other, 
from high school students like 
climate activist Greta Thunberg 
to protest movements in cities 
the world over.
Many Yale School of Medicine 
(YSM) faculty members have 
accounts on social media. They 
do their part to spread their 
for family and my eclectic inter-
ests (music, cinema, art) and 
sometimes activism.” Kaminski 
has almost 3,000 Twitter fol-
lowers, and posts frequently on 
various issues throughout the 
day. “For too long, physicians 





advice, Yale Center 
for Asylum Medicine 
helps asylum seekers 
clear legal hurdles in 
entering the country, 
raising the odds of a 
successful application 
by almost 50%.
For more on asylum  
seekers, visit  
ymm.yale.edu/asylum
the public eye,” he wrote. “It  
is our responsibility to be pres-
ent in the public domain, to 
share our work, our values, and 
our views.”
Another YSM faculty mem-
ber who is active on social 
media is Akiko Iwasaki, PhD, 
the Waldemar Von Zedtwitz 
Professor of Immunobiology, 
professor of molecular, cel-
lular and developmental biol-
ogy, and of dermatology, and 
a Howard Hughes Medical 
Institute investigator. Iwasaki is 
relatively new to Twitter—she 
created her account there in 
2017, and credits a former col-
league, Kellie Jurado, PhD, with 
helping to coach and mentor 
her in good habits of use. Now 
at over 11,000 followers, her 
handle, @VirusesImmunity, is 
considered highly influential 
in her communities of virol-
ogy and immunology, and she 
has issued several tweets that 
have, in contemporary parlance, 
“gone viral.” She does not use 
Facebook or LinkedIn frequently, 
though she maintains accounts 
there, preferring to focus on 
Twitter engagements.
Howard Forman, MD, MBA, 
professor of radiology and bio-
medical imaging and director of 
the MD/MBA Program at Yale, 
is another avid user of social 
media. His experience is akin 
to Kaminski’s; a self-described 
early adopter, he joined Twitter 
in 2008 but did not become 
active on it until 2016 (his 
handle, @thehowie, has over 
11,000 followers). “Timewise, 
I would say that Twitter is the 
only account that I attend to 
daily, for between five minutes 
and two hours of my time,” he 
wrote in an email.
Forman values Twitter for 
helping him “hone my posi-
tions,” as well as giving him an 
opportunity to evaluate view-
points different from his own. 
He said, “I have developed better 
skills at expressing my opinions. 
My skin is much thicker, both 
on social media and in real life, 
where I believe I take criticism 
more easily, particularly when it 
is offered in good faith.”
He cautions that social media 
can be dangerous for young pro-
fessionals. “I think you need to be 
very wary,” he wrote. “Earlier in 
one’s career, social media can be 
risky. If you have direct patient 
care responsibilities, you have to 
choose between having a truly 
public profile on social media or 
one that is more anonymous.  
If you choose to be public, which  
I think is generally preferable, 
you should consider how patients 
might respond to you if you are 
particularly aggressive in your 
political stances.” 
Iwasaki’s advice to faculty 
interested in creating social 
media accounts but unfamiliar 
with the terrain is more optimis-
tic. “Jump in!” she wrote. “Keep 
in mind that these posts are read 
by everyone. So, do be careful 
about the content, and make sure 
you are not inadvertently leaving 
out some people or being hurtful 
to others. The downside of social 
media is that there are always 
people who post negative or toxic 
comments (trolls). The upside is 
that you can reach thousands of 
people with words of encour-
agement and support instanta-
neously. The pros far outweigh 
the cons of being on social media. 
You will reach an audience you 
never thought possible!”
Other YSM faculty with 
extensive followings on Twitter 
include Harlan Krumholz, 
MD, the Harold H. Hines, Jr. 
Professor of Medicine (cardiol-
ogy) and director of the Center 
for Outcomes Research and 
Evaluation (CORE), (@hmkyale) 
who has over 15,000 followers 
there; and Roy S. Herbst, MD, 
PhD, the Ensign Professor of 
Medicine (medical oncology) and 
professor of pharmacology,  
(@DrRoyHerbstYale) with over 
2,500 followers. Some students 
and residents have outsize fol-
lowings on various social media 
platforms. And many YSM alumni 
are influential on social media, 
with some accounts, such as Esther 
Choo’s, MD ’01 (@choo_ek), boast-
ing nearly 100 thousand followers.
Social media is entrenched 
in most people’s personal lives, 
and plays an increasing role 
in how professionals talk with 
each other. Many of YSM’s fac-
ulty, students, and alumni are 
involved with the various plat-
forms. Depending on whether 
one prefers the advice of 
Iwasaki or Forman, one might 
decide to “jump in,” or hold 
off until later in one’s career. 




A form of automated intelligence (AI) may be better at dis-
tinguishing patients suffering from gastrointestinal difficul-
ties who can safely receive treatment at home from those 
requiring hospitalization, according to a recent study  
led by Dennis Shung, MD. Researchers looked at six medical 
centers around the world while creating their machine-
learning model. In the future, it’s possible that this type of 
program will enhance physicians’ diagnostic capabilities. 
AI PREFERS OUTPATIENT TREAT-
MENT FOR GI INFECTIONS
Only four of Connecticut’s 29 orthopaedic-specific urgent care 
centers accepted patients for treatment regardless of 
the patient’s insurance type, according to a study by Yale 
researchers, including Mary O’Connor, MD, director of YSM’s 
Center for Musculoskeletal Care, Daniel H. Wiznia, MD, 
assistant professor of orthopaedics and rehabilitation, and 
Christopher A. Schneble, MD, a second-year resident. 
This restrictive policy results in more patients looking 
for treatment in emergency departments. “Cherry-picking 
patients leads to systemic health care disparities,” said Wiznia.
MEDICAID MISSES MARK ON MUS-
CULOSKELETAL CARE
Carrie L. Lucas, PhD, assistant professor of immunobiology, 
led a team of researchers at Yale and at the National Institute of 
Health in sequencing the genome of a 9-year-old girl with a 
variety of unresolved health complications. Lucas and her col-
leagues discovered that the girl lacks a key protein—PI3Ky—which 
also figures in certain types of cancer. 
PROTEIN COULD BE KEY TO 
UNLOCKING IMMUNE DISORDERS
A total of 160 studies were published between 1981 and 2001 on 
the topic of psychiatric disorders in the wake of environmental 
disaster, at the rate of eight per year. According to a recent 
Yale School of Public Health study, in 2018, 178 articles were 
published on the subject, many in Asia. As worries about climate 
change increase, so too will research into what happens 
to individuals and populations affected by such natural catastro-
phes as hurricanes, tornados, floods, earthquakes, or fires.
STUDIES EXAMINE MENTAL HEALTH 
AFTER NATURAL DISASTERS
9Autumn 2019
a collection of recent  
scientific findings
DIVERSITY IS IN THE DNA OF SCIENCE. From such observers as Newton, 
whose attempts to understand the physical world around him gave rise to a 
world of testable hypotheses, to university researchers in the scientific revo-
lution in every country and culture that has practiced it, scientists’ discoveries 
are built upon conflicting information, different inputs, and varying perspec-
tives. Countries and cultures that historically lacked a diverse approach to 
science fared poorly compared to those with robust mechanisms for bringing 
in different perspectives.
The evidence of this benefit both anecdotally and scientifically, is over-
whelming. One well-known study published in 2014—“Collaborating With 
People Like Me: Ethnic Co-authorship Within the U.S.”—drew on over 2.5 mil-
lion research papers to determine that when scientists worked with people 
from different areas and ethnic backgrounds, and sourced their research more 
widely, the quality of their research was better. From a different vantage, a 
study conducted in 2018 by the Boston Consulting Group demonstrated that 
businesses with greater diversity across “gender, age, nation of origin (mean-
ing employees born in a country other than the one in which the company is 
headquartered), career path, industry background, and education” were 19% 
more profitable than homogenous competitors.
Given this and other evidence that diversity goes hand in hand with bet-
ter outcomes, the stories in this issue look at some of the ways in which Yale 
School of Medicine has continued to emphasize diversity across its research 
capabilities, curriculum, student body, faculty, and staff.
about the photographs
In an effort to visualize this diversity, Robert A. Lisak visited and photographed many familiar spaces 
around the medical campus. Long camera exposures cause moving figures to blur and nearly detach 
from the very traits that usually enable us to identify and categorize people, allowing viewers to focus 
more on the work that happens across Yale School of Medicine.
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Yale School of Medicine’s first Black graduate was 
Cortlandt Van Rensselaer Creed, MD ’57, who matriculated 
in 1853. The son of a New Haven bootmaker, Creed over-
came poverty and prejudice to serve as a surgeon with the 
Union Army during the Civil War. He corresponded with 
Frederick Douglass, and ran successful medical practices 
in New Haven and Brooklyn. An energetic and accom-
plished member of New Haven’s society and medical com-
munity, Creed more than justified his admission to Yale. 
According to the thesis of another far more recent 
Black graduate, U.S. Navy Captain Daryl K. Daniels, 
MD ’91, it took nearly 20 years for YSM to graduate its 
second and third Black doctors, and 12 more before 
it graduated its fourth. From then until 1960, when 
Captain Daniels’ study stops, the school graduated 
Black doctors sporadically and in small numbers. The 
first Black woman to graduate from YSM, Beatrix 
McCleary Hamburg, did not do so until 1948.
In the Civil Rights era, allowing and then facilitat-
ing equal access to medical education to all people 
became a major priority for Yale. Thus began the pro-
cess of creating a truly egalitarian learning experience; 
one that is far closer to reality in theory and practice 
today than at any time before.
“We put a lot of effort into making sure each class 
is as balanced and diverse as possible given the pool of 
applicants,” said Ayaska Fernando, director of admis-
sions. “We are fortunate to have the luxury of drawing 
on an incredibly diverse applicant pool, so each student 
can uniquely add to the School of Medicine; holistically, 
the class is strongest when those unique attributes are 
complementary to each other and collectively demon-
strate diversity across multiple fronts.”
YSM is dedicated to the education of students, first 
and foremost, and it’s unsurprising therefore that 
diversification efforts started in earnest with scholars 
matriculating at the institution. At the same time that 
YSM and peer institutions were beginning to vary their 
class compositions, they began efforts to do the same 
with faculty. Those initiatives gathered speed in the 
1970s and 80s. 
When it comes to the diversification of faculty gen-
der, several groups provided powerful advocacy over 
the years. The first formal standing committees dedi-
cated to the task were YSM’s Committee on the Status 
of Women in Medicine or SWIM, which celebrated its 
40th anniversary in 2019; and the Office for Women 
in Medicine or OWM (also begun in the late 1970s and 
the first such office in the United States). These groups 
secured important advances for women specifically 
and underrepresented minorities more broadly, espe-
cially in the last few years.
Nina Stachenfeld, PhD, senior research scientist 
in obstetrics, gynecology, and reproductive sciences, 
said “SWIM members as well as faculty and students 
in other organizations have been lobbying for our con-
stituents for years. We’re thrilled by recent wins, but a 
lot of hard work remains to be done.”
When SWIM started out in 1979, said Stachenfeld, 
the culture in medicine was aggressively patriarchal. 
This unfair system was perpetuated by a lack of 
women in leadership positions. And while female  
students were admitted to elite medical schools  
like YSM in more approximately equal numbers, that 
did not translate into positions for senior faculty or 
other leaders.
by adrian bonenberger
Yale School of Medicine’s students and faculty are a  
more varied group with each passing year, making for  
a more balanced place to study medicine.
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“What we’re talking about now, which we have 
been talking about for some years, is how to fix ‘the 
pipeline,’ ” Stachenfeld said. “This is the phenomenon 
where one has parity with female and male medical 
students, parity with junior faculty, and then, when it 
comes to chairs and deans, not much parity at all. We 
hope that status quo is changing.”
Other groups have organized to participate in driv-
ing parity beyond a balance between two genders; 
the Faculty Advisory Committee (FAC) and Minority 
Organization for Retention & Expansion (MORE) both 
examine areas in which historical or present-day 
minorities are underrepresented, and bring greater 
attention to them. This work is coordinated by and run 
through the Office of Diversity, Equity, and Inclusion. 
The head of the office, Darin Latimore, MD, is deputy 
dean and chief diversity officer. 
“It said a lot about Yale School of Medicine that 
they would create this role and empower it. Change 
can be difficult, but change is necessary for growth,” 
Latimore said.
Three of the many events that Latimore oversaw 
in 2019 included: “Q-Med: Building LGBTQI+ Leaders 
in Health Care,” held on March 30-31, believed to 
among the first of its kind; the Respect Retreat held 
on May 24, also believed to be the first of its kind at a 
U.S. medical school; and a panel held on October 30, 
“De-stigmatizing Disability: Tribulations and Triumphs 
of Disability at Yale.” The Respect Retreat featured 
Esther Choo, MPH, MD ’01, as well as the organization 
she helped co-found, TIME’S UP Healthcare. 
“Diversity and inclusion should be part of our every-
day practices,” said Latimore. “My hope is that some-
day this office is obsolete, that people understand how 
to respect each other and that our institution reflects 
those fundamental personal values.”
“We talk about it, but do we do it? That’s the ques-
tion I hope everyone is asking themselves,” said 
Latimore. In the meantime, he plans to continue assist-
ing the various allied groups and individuals on cam-
pus who are working to achieve equal representation.  
/yale medicine magazine



































Laboratories and departments increasingly seek intellectual 
and scientific breakthroughs through diversification.
Among the perks of working in the lab of Akiko 
Iwasaki, PhD, are the potluck meals at weekly lab par-
ties. The dishes, which range from Japanese sushi to 
Korean barbecue to empanadas, reflect the diversity  
of her lab team. 
“Not only do they come from different racial and cul-
tural backgrounds, but science backgrounds as well,” 
said Iwasaki, the Waldemar Von Zedtwitz Professor of 
Immunobiology and professor of molecular, cellular, 
and developmental biology and of dermatology, and a 
Howard Hughes Medical Institute investigator. “I have 
medical doctors, biologists, and people who are working 
in the computational side. When they get together, the 
kinds of things they can achieve together is much more 
than if I only have people of the same background.”
A case in point is the transgenic mouse Takehiro 
Takahashi, MD, PhD, made. “I was expecting to have 
some sort of phenotype related to autoimmune dis-
ease,” said Takahashi, who came to the lab two years 
ago with clinical experience and a background in  
neurology. “What I actually noticed was the gait— 
they lose balance very easily. We never expected the 
mice to have a neurological problem.”
And Takahashi’s training in neurology is why 
Iwasaki celebrates the diversity of people from differ-
ent fields working together. “There’s a lot of research 
done over the decades that shows that diverse teams 
produce more innovative discoveries in science,” she 
said. “In order to have synergy between team members 
you need to have diversity.”
That synergy has remained elusive in a university 
setting. The Society for Experimental Biology and 
Medicine was founded in 1903 to promote biomedical 
research across disciplines. More than a century later, 
in 2006, the society’s journal published this article, 
“The Future of Interdisciplinary Research and Training: 
How to Conquer the Silo Guardians.”
Such barriers to cross-disciplinary diversity, said Gary 
Brudvig, PhD, the Benjamin Silliman Professor of Chemistry 
and professor of molecular biophysics and biochemistry, 
are embedded within the structure of academia.
“The sciences are typically departmentally organized 
and very siloed,” he said. “Chemistry is in one build-
ing and chemists see each other all the time, but they 
never interact with other people unless there is some 
reason to seek each other out. It’s not a very organic 
process of creating interdisciplinary research, which is 
becoming more and more important.”
About 15 years ago, Brudvig and colleagues created 
an institute that brought together scientists from differ-
ent fields who shared an interest in climate and energy. 
The institute lasted about six years and was supplanted 
when Yale bought the West Campus in 2007 and cre-
ated the Energy Sciences Institute (ESI), which Brudvig 
directs. “It created a very different environment,” he 
said. “It’s focused on a topic, not a discipline.”
Faculty at the institute come from applied physics, 
mechanical engineering, chemistry, and chemical and 
environmental engineering. Researchers from such fields 
as electrical engineering, geology and geophysics, and 
molecular biophysics and biochemistry are present on the 
institute’s advisory board.
The federal government, Brudvig noted, has encour-
aged interdisciplinary research over the last decade. 
“Grants may be on a particular topic, but the scope 
requires people with expertise in different areas,” he said.
At the ESI, the success of cross-disciplinary 
research is reflected in its publications, written by 
authors from different departments. And Brudvig 
points to the serendipity that comes from proximity. 
Discovery potluck
ymm.yale.edu16
Over lunch, he said, one of his postdocs chatted with a 
scientist from a lab that needed help making molecules 
to improve battery life. Brudvig’s postdoc knew how to 
make those molecules.
“That collaboration got started without either prin-
cipal investigator being aware of it, and it led to other 
projects,” he said.
Bringing people together was the foremost goal of 
All Points West, a half-day symposium organized by 
graduate students this spring at Yale West Campus, 
where institutes are arranged according to theme 
rather than discipline.
“We wanted to get people across different disciplines 
talking to each other,” said organizer Courtney Smith, 
a fifth-year student in the Cancer Biology Institute. 
“It’s easy to chat with people within your own institute, 
but I hadn’t seen many events on campus aimed at 
bringing the different institutes together.”
“On occasions when I did hear from other institutes, 
it was normally at the faculty level,” said Becky LaCroix, 
a seventh-year student at the Systems Biology Institute, 
and co-organizer of the symposium. “This really felt like 
a space for everyone to learn what’s going on.”
Students from each of the seven institutes plus the 
Yale School of Nursing made five-minute research pre-
sentations at a level “scholars from all backgrounds 
could understand,” Smith said. They also submitted 
proposals for mini-grants to fund a year of research. 
One of the three awarded was for a collaboration 
between postdocs Eileen Condon from the School of 
Nursing and Sylvie Estrela from the Microbial Sciences 
Institute to look at how maternal stress might be 
transmitted to a child via the gut microbiome.
LaCroix and Smith plan to repeat the symposium 
next year. “We wanted to provide trainees with some 
way to connect,” Smith said. “That is the goal of this 
campus, to be collaborative.” /yale medicine magazine


















Why homogeneity in the lab can hinder progress.
Change is a constant, and it takes a wide variety of responses to best meet it. Within 
groups of people, diversity is the fertile ground from which fresh new ideas can spring. 
“Homogeneity minimizes adaptability,” said John Dovidio, PhD, the Carl I. Hovland Pro-
fessor of Psychology and professor in the Institute for Social and Policy Studies and of 
epidemiology. “When you only have one way of doing something, you become a dino-
saur. If conditions change—or if what you do well doesn’t have an audience or a group 
of people that want it—it’s over.”
By contrast, Dovidio said, “There is a lot of research that shows that groups that 
have more diversity are more creative; are more flexible; are more adaptable.” In di-
verse groups, the tensions that develop may be creative, forcing people to think more 
complexly, he said. That can lead to more adaptability and more empathy, as members 
must maintain a more nuanced worldview about everyone else in the group. 
Ethnically diverse juries, for instance, think more deeply about the issues in trials 
involving race than all-white juries do. Similar phenomena has been found in academic 
organizations, industrial settings, and the legal system. There’s also evidence that 
intercultural experience correlates with a higher level of creativity.
It’s true in science, too, said immunobiology professor Akiko Iwasaki, whose lab 
includes researchers educated in China, Japan, and Korea. “I’m a strong believer in di-
versity, and I try to implement that in my own laboratory. Diverse teams produce more 
innovative discoveries,” Iwasaki said. Indeed, scientific papers with a more diverse au-
thor lineup tend to include more references and to have a greater effect on their fields 
than those with a more homogeneous group of authors. 
There are undeniable downsides to maintaining a diverse group, however. “Socially, 
it’s difficult to manage,” Dovidio said. “You have more social tension. You may have 
some more, at least initially, misunderstandings. … Diversity requires some manage-
ment and cultivation and attention that homogeneity doesn’t.” That management 
could include encouraging people to think of themselves as members of the larger 
group rather than of subgroups, while simultaneously taking care not to gloss over 
important differences to create a “veneer of harmony,” he said. 
For example, we can “get people to say that we are connected in a positive way with 
one another—we are Americans—but that we come in different flavors.” It can be difficult 
for groups to navigate that kind of discomfort. But a rich reward often awaits those that 
succeed. “The benefits of diversity are not simply about helping minorities,” Dovidio said. 
Rather, diversity “is also about helping majority group members—helping people who 
identify with the whole system—to be much better, more complex, more flexible.”
—Jenny Blair, MD ’04

















by carolyn m. mazure, phd
The changing ways in which women have been 
included and studied at Yale School of Medicine over 
the years is a useful gauge of progress.
When we think of diversity at an academic medical 
center, our focus tends toward reviewing the composi-
tion of our faculty, students, and staff, and ensuring that 
our academic community is broadly representative of 
our population at large. In addition to inclusion of “the 
many” being the right thing to do, diversity fosters a 
more creative and productive working environment.
To build diversity within our school, one goal has 
been to increase the number of faculty members who 
are women; and over many years, the school has con-
sidered how to make the environment more welcoming 
to women and supportive of their academic careers.
In 1988, for example, Dean Leon Rosenberg, MD, 
HS ’63, formed a task force to design a plan for increas-
ing the number of women at all faculty levels. The task 
force report indicates that as of 1988, “Many people in 
academia assume that discrimination against women 
has ended, since there has been a significant increase 
in the number of women students, house staff, and 
junior faculty in recent years.” As evidence of this at 
YSM, 1988 data are provided to show that 33% of our 
entering class of medical students were women. Yet, as 
this thoughtful report also points out, “women occupy 
only 7% of the total tenured faculty of 254 …,” and the 
change in the number of women entering the medical 
community has been due “in part to the enactment 
of anti-discrimination legislation in 1964.” The report 
concludes that women remain underrepresented, and 
identifies a “perception bias” about how women per-
form as faculty that holds back their full inclusion.
There is much more to this careful report and numer-
ous subsequent reports, such as the 1994 Report of the 
Dean’s Task Force on Senior Women in the School of 
Medicine constituted by Dean Gerard Burrow, MD ’58, 
HS ’66; the 2003 Report from the Commission on 
Women Faculty, requested by Dean David Kessler, MD; 
the 2015 Ad Hoc Task Force on Gender Equity, and  
others focusing on various aspects of gender equity. 
Each has marked renewed effort in advancing the met-
rics of change, and these metrics now show that over 
half of our entering medical school class are women and 
a quarter of tenured faculty are women.
However, these more recent metrics do not obscure 
the significant challenges that remain. And here we 
turn to a common thread initially reported by the 1988 
task force and reflected across subsequent reports. This 
thread is the notion of a perception bias about women, 
a bias which must be countered by gathering objective 
data that show the many and varied contributions of 
women faculty. 
This struggle for inclusion of women extends to 
whom we study and for whom we develop our treat-
ments and prevention strategies. In research, there has 
been a perception bias about the need to study women.
It was not until the 1993 NIH Revitalization Act 
was implemented that the National Institutes of 
Health required that women be included as study 
participants in NIH-funded studies. Prior to that time, 
the prevailing tradition was not to include women in 
clinical trials or analyze data by sex or gender, leaving 
Inclusion of women  
as a diversity measure
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an enormous gap in our knowledge about the health 
of women. 
Of the three main reasons for excluding women, 
one revolved around the commitment to protect 
women from experimental risk that could adversely 
affect childbearing. Though an important goal, this 
restriction for inclusion as a study participant became 
broadly applied to women. The Institute of Medicine’s 
study on ethical and legal issues on the inclusion 
of women found that protectionist policies did not 
account for all inattention to the study of women’s 
health and concluded that inattention also arises from 
biases that permeate society and science. The sec-
ond reason women were generally not included was 
predicated on the misinformation that women are less 
affected by many health conditions and, if affected, 
syndromes and responses are the same across genders. 
Finally, women were often not included due to the 
“complexity” that hormonal variation brought to a sci-
entific study. Yet, this raises the question—doesn’t this 
variation, as well as other sex-specific factors, actually 
require the study of both women and men? To be sure, 
some studies included women if a condition is unique 
to women, such as reproductive cancers, or if a condi-
tion is highly prevalent in women, such as depression. 
However, in these latter studies, data were not ana-
lyzed for sex or gender differences, again leaving an 
important knowledge gap for women and men. 
Women’s Health Research at Yale (WHRY) was 
founded in 1998 to ensure a leadership role at YSM in 
remediating these gaps—knowing that, as indicated by 
the American College of Physicians, women are more 
likely to suffer from chronic diseases and disability as 
well as acute and chronic pain, die following a heart 
attack, develop depression and anxiety, have autoim-
mune diseases, and develop Alzheimer’s disease.
Since its inception, WHRY’s goals have been to 
ensure women’s lives are advanced through research 
and its clinical translation; share new findings with 
the public to inform personal health decisions; and 
promote the study of difference between and among 
women and men to enhance the well-being of all. 
Moreover, WHRY’s goals include setting the stage for 
important discovery in basic science by always includ-
ing females in studies using vertebrate model systems, 
as now required by the NIH. With these goals in mind, 
WHRY has initiated new studies and research col-
laborations, and funded over 100 faculty projects from 
19 YSM departments, sparking innovation and produc-
tivity in uncovering new findings on pressing health 
concerns for women ranging from cancers to cardio-
vascular disease. 
For example, WHRY-affiliated Yale investigators 
have uncovered metabolic and signaling pathways for 
a colon cancer prevalent in women, differential effects 
of stress on neurodevelopment in adolescent girls and 
boys, a new treatment for autism in girls, an innova-
tive therapeutic “prime-and-pull” vaccination strategy 
to prevent sexually transmitted infections and cervical 
cancer, and a more effective taxonomy for identifying 
acute myocardial infarction in women—among many 
other useful and meaningful discoveries. Importantly, 
our funded investigators subsequently have generated 
over $100 million of new research grants to pursue the 
research they have launched with WHRY support.
Maintaining the trajectory of progress in studying 
women and sex/gender differences requires believ-
ing there is value in diversity and retiring the notion 
that difference means better or worse. The metrics of 
diversity are important in assessing our progress, but 
fundamentally diversity is about perspective. Teaching 
the next generation of investigators and clinicians 
about the value of diversity and modeling inclusiveness 
is what will secure progress for human health and our 
scientific future. /yale medicine magazine



















For some MDs, a commitment to medicine extends 
beyond the exam room or the lab bench. “I often 
advise students that the first career they choose isn’t 
necessarily what they’re going to be doing forever,” 
said Lisa Ide, MD ’89, MPH, the chief medical officer 
of Zipnosis, a virtual health care technology company. 
This mindset might not surprise millennials, who are 
increasingly likely to anticipate having a series of dif-
ferent careers rather than a single lifelong one. For 
most medical students, though, the standard postgrad-
uate path is residency followed by academia or clinical 
practice. Some alumni of the Yale School of Medicine, 
however, have managed to use their MDs in unortho-
dox ways.
“I’m struck by the zigs and zags,” Rob Kolodner, 
MD ’74, vice president and chief medical officer of the 
telehealth company ViTel Net, said of his own journey 
after medical school. Neither Ide nor Kolodner, both of 
whom appeared on an alumni panel on career transi-
tions in June, intended to pursue the work they ended 
up choosing. Ide recalls a pivotal moment during an 
overnight shift in the emergency department, when 
her patient—a mother with a young son in tow—waited 
hours to receive treatment for an uncomplicated ear 
infection. Ide’s frustration with clinical inefficiency 
shifted her focus from individual patient care to 
improving population-wide access to health care. She 
pursued an MPH degree and a second residency in 
occupational health, which equipped her for employee 
health leadership positions at General Mills and 
Fairview Health Services. 
Yet another pivot brought her management exper-
tise back to the problems she’d encountered in the 
emergency department: at Zipnosis, she and her team 
of software engineers strategize ways to streamline 
care delivery. “I love coming to work, knowing that 
my job is to prevent that mom and her son from sitting 
in the ED.” 
Kolodner was also drawn to data that improve 
patient care and came to medicine with a basic 
understanding of computer programming. During his 
residency in the 1970s, he was one of the few psychia-
trists who used a computer to manage research refer-
ences. “Looking at this data made me realize that there 
was an awful lot coming out of the literature that the 
practitioner wasn’t using.” He accepted a position as 
the director of medical information resource manage-
ment at the Department of Veterans Affairs (VA), and 
proposed providing each VA hospital with a computer. 
Despite initial bureaucratic pushback, Kolodner’s team 
implemented the world’s first large-scale electronic 
health system. As the national coordinator for health 
information technology, he continued advocating for 
health information systems. At ViTel Net, he now uses 
technology to empower individuals to control their 
own health care. 
Connecting people from different disciplines has 
been a defining component of each role he’s occupied. 
“The type of innovating I do is combining existing things 
in new and exciting ways. It requires adaptability.”
The flexibility of Yale’s curriculum may prepare 
alumni for unconventional occupations, and for the 
Most people attend medical school to become physicians; 
some, however, use their degrees to pursue other goals.




uncertainty that comes along with them. “The Yale 
system taught me how to learn and keep learning,” Ide 
said. “With each pivot, I felt comfortable jumping in 
and developing new skills.”
Alumni like Ide and Kolodner trained for their 
nonmedical pursuits on the job, but other students 
seek dual degrees in preparation for unconventional 
paths. Yale offers a number of joint degree programs in 
areas like policy, law, business, history, forestry, and 
theology, among others. Barbara Kazmierczak, MD, 
PhD, the director of Yale’s MD-PhD program, said that 
students pursuing nontraditional scholarship bring 
distinctive insights and goals. “Compared to other 
physician-scientists we’re training, these students 
are often drawn more explicitly to shaping the way in 
which medicine is practiced or perceived.” 
Marco Ramos, MD ’18, PhD ’16, pursued a PhD in 
history of science and medicine alongside his medi-
cal training. His historical research, which focuses on 
health activism in the Global South, was informed by 
his clinical interests in psychiatry. His own engage-
ment with social justice in medicine is bolstered by 
rigorous historical evidence. “It was an opportunity 
to deliberately blur the lines between the sciences, 
humanities, clinical work, and political action.”
While YSM offers and encourages interdisciplinary 
pursuits, it also emphasizes clinical leadership. “It makes 
a difference when health companies have a practicing 
physician on their team,” said Ide. “They understand 
what it’s actually like to be responsible for a whole panel 
of patients or struggle with electronic medical records.” 
Howard Forman, MD, MBA, the director of Yale’s MD/
MBA program, said that the joint degree prepares stu-
dents to work in a variety of fields—its graduates are lead-
ers in politics, technology, and global health—but, only 
three students in the program’s 20-year history have 
opted out of matching into a residency. He’s proud of 
these numbers—in peer programs, the proportion of stu-
dents leaving medicine is closer to one-third or one-half. 
Preparing for an unconventional trajectory implies 
a willingness to pursue interdisciplinary work. 
Kolodner suspects that these alums will be surprised 
by their paths. “They’re laying a rich foundation and 
acquiring skills earlier on, but they’ll likely follow 
the same zigs and zags, the unanticipated things that 
push us in different and exciting directions.” /yale 
medicine magazine



































Yale School of Medicine administrators, faculty, and stu-
dents work together to make sure the school’s academic 
offerings minimize potentially harmful distractions. 
For most of its history, the School of Medicine was 
a place where young white men learned from older 
white men. Those days are gone. Black men and women 
trickled into the medical school in the middle of the 
20th century. By the 1990s, women made up half of 
each medical school class and the presence of minority 
students was increasing.
Still, attitudes, biases, and stereotypes have lingered 
in the curriculum. Across the country, medical schools 
are recognizing that lab tests and vital signs don’t tell 
the whole story; and that to provide the best care, doc-
tors must understand how race, gender, sexual orien-
tation, poverty, and access to health care affect their 
patients’ health—as well as their own inherent biases.
This concern is not just academic. Knowing about 
patients’ lives has consequences for their care. “If we 
are ever going to get to the point of closing health care 
disparities, physicians of tomorrow must have a much 
better understanding of the people they are treating,” 
said Darin Latimore, MD, deputy dean for diversity 
and inclusion.
A fourth-year MD-PhD student on the Committee 
for Diversity, Inclusion, and Social Justice put it more 
forcefully. “People are dying and suffering due to 
lack of appropriate care that can stem from provid-
ers’ biases and false or inaccurate information from 





For years, students have been advocating for a 
curriculum that recognizes the importance of social 
determinants of health. Their efforts bore fruit at 
a town hall in November 2015 with Dean Robert J. 
Alpern, MD, Ensign Professor of Medicine, when led 
by the organization NextYSM, students voiced their 
concerns. In addition to changes in the curriculum, 
they highlighted the need for more support for minor-
ity students, more minority faculty, reporting on bias 
incidents, and recruitment of a diversity officer. 
The Dean’s Committee for Diversity, Inclusion, and 
Social Justice was created as a result, and the school’s 
Educational Policy and Curriculum Committee (EPCC) 
began looking into the curriculum. In March 2018, 
an EPCC subcommittee recommended enhancing 
opportunities for health equity research, creating a 
certificate in health justice, promoting professional 
development, establishing a social mission statement, 
and showing a commitment to faculty diversity. Two 
key elements of the plan were weaving a health equity 
thread throughout all four years of medical school and 
creating a requirement for community service.
The subcommittee, chaired by Marcella Nuñez-
Smith, MD, MHS ’06, associate professor of medicine 
(general medicine), and of epidemiology (chronic 
diseases), and director of the Equity Research and 
Innovation Center, interviewed students, faculty, and 
representatives of community-based organizations.
“We reviewed the curriculum to see how it covered 
issues of social determinants of health, not only in 
terms of where they are covered, but the quality of  
that coverage,” said student and committee member 
Ram Sundaresh. “There were some areas where it  
was covered adequately, but we identified a lot of areas 
for improvement.”
“The concept of race in the curriculum and clinical 
care is raised all the time, but we don’t really teach it 
in a rigorous way,” said Nientara Anderson, a fourth-
year medical student on the committee. “Race-related 
terms aren’t talked about in ways that are up to speed 
with current scholarship.”
Anderson said it’s not just a matter of how patients 
are treated. People of color and varying sexual identi-
ties and orientations are present in today’s classrooms. 
“Every time these issues are treated in an ignorant, 
incorrect, insensitive, discriminatory, or biased way, 
there are people in the classroom experiencing dis-
comfort, alienation of professional identity, a sense 
of not belonging in the classroom, a sense of being 
singled out or insulted by the way things are being 
taught,” said Anderson.
Both the diversity thread and community engage-
ment are works in progress. The medical school has hired 
a community-based experiential learning coordinator 
and is interviewing for the post of equity thread leader. 
The school is coordinating with community groups and 
neighboring universities whose students are also engaged 
in health projects in New Haven. 
“Students from many colleges and universities volun-
teer in the greater New Haven community. It is unreal-
istic for us to assume that a local nonprofit would know 
which projects are best suited for an undergraduate ver-
sus a pharmacy student or medical student, for example. 
Part of our task is to create an effective method of 
pairing our students with community agencies that 
will benefit from the unique skills and knowledge that 
medical students bring to the table.”
Latimore said that while the school is in the early 
stages of “figuring out what the curriculum should 
look like,” the goals are clear.
“When a student takes a history, if they ask, ‘Do you 
have food hunger?’ and they hear ‘yes,’ I want them  
to say, ‘Here are agencies that can help you,’ ” he said. 
“If the students only learn that African Americans 
experience certain diseases at a higher rate, or that 
the LGBTQ community faces certain diseases at a spe-
cific rate, but do not ask the deeper questions about 
the patient’s ‘lived experiences,’ we will not have met 
the mark. We hope that our students will leave with a 
curiosity about and understanding of the complexity of 
the individual sitting before them, with the humility 
to learn, and with a knowledge of the resources that 
they can offer that person.” /yale medicine magazine




































A board game to ease the stress of learning organic chemistry.
by adrian bonenberger
Most students hoping to enter medical school view organic 
chemistry, colloquially called “orgo,” with apprehension 
and fear; failure to excel in the course means risking one’s 
chances of admission to a good institution. Failure to pass 
the course means dooming one’s dreams of becoming a 
doctor entirely.
Prerak Juthani, however, a third-year student at Yale 
School of Medicine, loved his time in organic chemistry. 
He saw it as a game in which you had to use different 
chemicals to synthesize unique substances.
“I enjoyed that class, but I understand why people 
struggle,” said Juthani. While he is aware of the course’s 
dire reputation, he believes that the problem is not 
with the material so much as the context surrounding 
the course, and existing pedagogical approaches to it. 
“Organic chemistry is a very unusual class in the sciences, 
and people have to study for it differently, which throws 
them for a curve.”
That’s why Juthani co-founded REACT! with a 
University of California, Berkeley undergraduate while he 
was there. REACT! takes study aid to a whole new level, 
combining attributes of board games with attributes of 
a card game, all dedicated to helping students master 
organic chemistry.
“Because of my passion for it, I began to tutor strug-
gling students, and in the process figured that I could turn 
the concepts of organic chemistry into a study aid,” said 
Juthani. “I got together with a couple friends, and the 
more we talked about it, the more we realized orgo could 
be gamified—turned into a competitive game.”
According to statista.com, a website dedicated to 
aggregating and analyzing market data, the global 
board game industry in 2019 is worth approximately 
$8.5 billion. That makes a study aid that’s pitched 
in a board game format a good bet financially—and 
an excellent fit for the intellectually stimulated 
high-achieving undergraduates who must take the 
daunting class in order to matriculate at medical or 
graduate school.
After raising money through a Kickstarter campaign—
over $15,000—the team was ready to take it live. Now, 
REACT! is available at $40 per set. The game, played by two 
to four people, includes 212 cards, four reaction maps, four 
“lab benches,” four dry-erase markers, and one manual. 
“The goal is to score as many points as possible,” said 
Juthani. “You can score many points by saving up and 
making one big compound, or score a few points many 
times with smaller reactions. That’s the element of strat-
egy in the game, knowing what’s out there and seeing a 
viable path based on the reagent cards in your hand.”
According to the co-president of REACT!, Daniel 
Rosenthal, helping people learn science comes naturally 
to Juthani. “We met in 2015, a year before Prerak started 
REACT! He was an energetic student-leader, tutoring 
hundreds of UC Berkeley students in biology and chemis-
try at UC Berkeley’s Student Learning Center.”
Rosenthal believes great things are in store for REACT!, 
and also for his colleague: “Prerak is dynamic, driven, 
and innovative. Now that he’s at Yale School of Medicine, 
he’s encouraging me to guide our team and take REACT! 
to new heights.”
For Juthani’s part, he’s excited about ways to connect 
with people in and provide value to the New Haven com-
munity. Though it took a little while to adjust from his 
native San Francisco, Juthani said YSM feels like home. 
“There are so many things happening here at Yale School 
of Medicine, it can be overwhelming. But once I had spent 
a couple months here, I found my people and have been 
able to create a community that drives me to continually 
do bigger and better things. I’m hoping to continue pur-
suing my passion of entrepreneurship by doing an MBA 
here in the near future.” /yale medicine magazine


















Yale School of Medicine (YSM) in the 21st century is 
rightly considered a world-class institution, while  
the city that surrounds it is equally renowned for  
the excellence of its hospitals and biotechnology com-
panies. Today, the relationship between YSM and  
New Haven is strong, but it wasn’t always that way:  
the pair has weathered setbacks in their growth and 
their relationship. 
YSM was founded during a period in which profes-
sional schools in law, medicine, and theology separated 
from undergraduate colleges. The Medical Institution of 
Yale College, as it was then known, was not chartered 
until 1810. Its beginnings in a building on Prospect 
Street soon brought it into conflict with the townsfolk, 
then numbering fewer than 7,000 souls. A riot broke 
out in 1824 when the body of a young woman taken 
from the cemetery was discovered in the cellar of the 
Medical Institution. While New Haveners held general 
medical practice in high regard, dissection associated 
with grave robbing was taboo.
by rebecca j. frey, phd ’99
A complex but enduring 
partnership
After two centuries of shared history, the School of Medicine 
and the city of New Haven continue to shape each other.
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The Industrial Revolution brought many changes 
to city and school alike, not all of them positive. New 
Haven’s 1830s investment in building a canal northward 
to Northampton squandered capital that could have 
been used to build a railroad. On the other hand, Eli 
Whitney’s cotton gin and gun factory brought prosper-
ity to the city and turned it into a manufacturing center 
for military equipment. As a result, New Haven’s popu-
lation grew from 20,000 in 1850 to 40,000 only 10 years 
later. The medical school made its own history in this 
period by graduating its first African American student 
in 1857 and by moving to York Street in 1860. It became 
the official medical school of the university in 1887.
YSM’s stature declined after the 1890s, however. 
Abraham Flexner noted in his famous 1910 report 
on American medical education that although Yale 
compared favorably to medical schools that were not 
university-affiliated, its departments of anatomy, bac-
teriology, and pathology were deficient; its professors 
had to do routine work rather than research because 
they lacked assistants; and the study of obstetrics and 
gynecology was limited to the outpatient clinic in the 
hospital. World War I brought two important innova-
tions: the establishment of the Department of Public 
Health (later to become a separate school) in 1915, and 
the admission of the first women students in 1916. 
But the school’s four buildings were scattered across 
downtown New Haven, and it had to rely on the uni-
versity to cover its debts. 
It was Milton Winternitz, MD, who transformed YSM 
from the university’s stepchild to a national leader in 
medical education. Winternitz, dean from 1920 to 1935, 
not only raised money to give the school financial stabil-
ity, but also supervised its move to its present location 
next to what is now Yale New Haven Hospital. He added 
the Department of Psychiatry and the School of Nursing 
as well as recruited a stellar faculty that brought YSM 
into the front rank of American medical schools. Most 
importantly, he introduced the Yale system, an approach 
unique to YSM that deemphasizes grades and class rank-
ing, and encourages medical students to become flexible 
and independent thinkers (as their varied postgraduate 
careers demonstrate). Winternitz’s requirement of a the-
sis for the MD degree is one reason why a high number of 
YSM graduates still enter academic medicine.
The 1950s witnessed the impact of the automobile 
and the construction of interstate highways on both 
the city and its medical school. As the city’s popula-
tion grew to a postwar high of 160,000 and its medical 
center attracted increasing traffic, Mayor Richard C. 
Lee decided in 1957 to tear down a Jewish, Irish, and 
Italian immigrant neighborhood near the hospital to 
make room for an expressway and two frontage roads. 
In addition to destroying one of New Haven’s most 
distinctive areas, the Oak Street Connector severed 
the medical center from the rest of the university and 
introduced numerous hazards for drivers and pedes-
trians alike. Downtown Crossing, a three-phase proj-
ect to redesign the expressway is currently in Phase 
2. Completion is scheduled in 2021. Planners hope it 
makes New Haven friendlier to people commuting 
by foot—after all, the city has a higher percentage of 
residents who walk to work than any other city in 
New England.
YSM contributes to the revitalization of downtown 
New Haven in several ways—first, by ensuring that 
all its new buildings meet Leadership in Energy and 
Environmental Design (LEED) certification standards. 
Second, the school is working with the city to make 
the medical campus more pedestrian-friendly. Most 
importantly, however, YSM is deeply involved with 
the surrounding community to meet its most press-
ing health care needs. Faculty and students provide 
care for people in a wide range of settings, from YSM’s 
refugee clinic for adults and the student-run HAVEN 
Free Clinic in Fair Haven to the Neighborhood Health 
Project (which provides free diabetes and blood pres-
sure screenings) and an expanded addiction medicine 
program. While many challenges remain in regard to 
human need as well as urban infrastructure, YSM and 
New Haven are committed to meet them as partners.  
/yale medicine magazine



































by jenny blair, md ’04
The outside world teems with microscopic objects. 
Many of these busy microbes invade the human body. 
Viruses, pollen, bacteria, fungi, toxins, mineral par-
ticles, soot, and—these days—microplastics permeate 
the food we eat and the air we breathe.
To combat this assault, the body uses a diverse tool 
kit: the immune system. The body’s response to threats 
depends upon its ability to generate an omnifarious 
defense, while the microbiome lining the gut surface 
contains a complexity that protects and sustains us 
in more ways than one. It’s tempting to conclude that 
diversity is always a faithful ally.
When a vertebrate immune system faces a new 
pathogen, it comes prepared with a variety of weapons. 
“The immune system is all about diversity,” said Akiko 
Iwasaki, PhD, the Waldemar Von Zedtwitz Professor 
of Immunobiology, professor of molecular, cellular, 
and developmental biology, and of dermatology, and a 
Howard Hughes Medical Institute investigator. 
Each young cell of the adaptive immune response 
begins life wielding a unique appendage—a single type 
of receptor. Each receptor is generated afresh, one per 
cell, by genes that recombine and mutate rapidly. 
If the pathogen happens to fit a single cell’s recep-
tor—an event analogous to a random key fitting a 
lock—the lymphocyte that wields it begins to divide. 
Equipped with the correct receptor, all the cell’s prog-
eny can more effectively meet the intruder. 
Absent this process, there would be no adaptive 
immune response—a “clear example of diversity being 
required for survival,” Iwasaki said.
Similarly, at the population level, individual people 
muster a variable array of immune responses that limit 
the damage that any specific pathogen can do. People 
contract infectious diseases all the time, but  
few people are killed by them, save in examples in 
which people are immunocompromised or in cases 
where the pathogen is extremely deadly.
(Iwasaki has argued that the immunology commu-
nity itself ought to follow similar principles in its own 
ranks, criticizing the ubiquity of homogeneous panels 
and speakers at research symposia.) 
Then there is the gut microbiome. In recent years, 
studies about it have flourished, even as researchers have 
come to suspect that this inner ecosystem is growing less 
diverse due to restricted diets and antibiotic overpre-
scribing over several decades. This loss of diversity is, it 
appears, to our detriment: a higher number of species in 
the gut microbiota seems to correlate with better health. 
Severe loss of diversity in the gut microbiome can 
predispose a person to opportunistic infections. The 
classic example is Clostridium difficile infection (CDI), 
which can take hold after chronic antibiotic use eradi-
cates ordinary gut residents. As it flourishes, CDI can 
cause a life-threatening diarrhea.
“[Antibiotic use can be] like clearing the rainforest 
in the gut,” said Noah Palm, PhD ’11, assistant profes-
sor of immunobiology. “This weed that was hiding in 
the background as spores is able to grow.” 
Until recently, physicians treated repeat CDI epi-
sodes with antibiotics, a tactic comparable to burning 
over the same ground again and again. An alternative 
approach: replace the dangerously simple ecosystem 
with a diverse one using a fecal microbiota trans-
plant. With cure rates topping 90%, it is now first-line 
therapy for third or subsequent nonsevere episodes of 
recurrent CDI. This success has inspired researchers to 
experiment with fecal microbiota transplantation in a 
wide variety of other diseases, including autoimmune 
disease, autism, and cancer. 
Microbial biodiversity helps keep humans healthy by shielding 
them from fatal infections.
A disease deflector
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Why did we evolve such a diverse gut community 
in the first place? One explanation is that it can shield 
us from colonization by pathogens, Palm said. Without 
friendly bacteria occupying all available ecological 
niches in the gut, a person is profoundly susceptible to 
infectious disease. 
As an example, to infect a healthy mouse with 
Salmonella requires something like 100 million 
individual bacteria. But if you dose that mouse with 
an antibiotic, thus eradicating part of its gut flora, 
it may take only 100 or even 10 Salmonella cells to 
cause infection. 
“In my opinion, that’s the most important rule 
that the microbiota plays evolutionarily,” Palm said. 
“Without our microbiota, for that reason alone, all of us 
would be dead from pathogenic infection.”
Over deep time, a certain level of gut microbiome 
diversity has become necessary for another reason: 
nutrition. We’ve lost the ability to synthesize certain 
vitamins on our own, instead depending on specific 
microbes to perform that metabolic task. The gut 
microbiome, too, can unlock complex carbohydrates 
whose nutrients would otherwise be out of reach.
On a local level, though, greater diversity isn’t nec-
essarily better. Compared with the gut, for instance, 
the vagina prefers a far simpler microbiome. Whether 
the lung does best with a wide or narrow range of 
organisms remains to be determined.
Andrew Goodman, PhD, the C.N.H. Long Professor 
of Microbial Pathogenesis, and director of the Yale 
Microbial Sciences Institute, emphasizes the impor-
tance of avoiding the reflexive belief that diversity is 
invariably beneficial to biological systems. 
In clinical care, for example, fecal transplantation 
has not fulfilled everyone’s hopes.
“To date, [CDI is] really the only example where there’s 
been widespread clinical application of a microbiome-
based therapy that’s gone beyond a few isolated trials,” 
Goodman said. 
Even in the gut, the addition of a new kind of 
microbe—ratcheting up the diversity, he points out—is 
arguably less healthful if the newcomer is a pathogen.
Palm added that many recent non-CDI fecal trans-
plantation trials have little basis beyond hope on which 
to proceed. 
“People are throwing darts at a wall without under-
standing what’s going on” he said. “It’s much less clear 
that loss of diversity is actually a cause of disease in 
these other, more chronic disorders.”
“The idea of diversity being good, I think, has 
caught hold because it’s an attractive idea, and fits 
with our concepts also of biodiversity environmen-
tally,” Palm added. “It’ll be interesting … to figure out 
in a bit more mechanistic detail when and why it’s 
actually good to have diversity, and get beyond some 
of these generalizations.” 
If fecal transplantation turns out not to be a pana-
cea, what other roles might gut biodiversity play 
in clinical care? Goodman, for his part, is studying 
the role played by the gut microbiome in the body’s 
response to medications. People with the same dis-
ease can have different responses to the same drug. 
Some of that variability may be explained by differ-
ences in the human genome, but the gut microbiome’s 
genome, which dwarfs that of its human host, may 
also be involved. 
Goodman points out that researchers have identi-
fied gut microbes that metabolize two-thirds of the 
medications they’ve examined. How those metabolites 
affect the host is still unknown, he said, “but at least 
the potential is there. We’re just starting to understand 
the rules.” 
“I’ve always been interested in the molecular mech-
anisms of gut microbial ecology. We have a lot more 
to learn,” Goodman said. “It’s a very fun time and a 
very exciting time to be in the field.” /yale medicine 
magazine
Jenny Blair is a frequent contributor to Yale Medicine Magazine.
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Wander the maze of inter-
connected Yale New Haven 
Hospital (YNHH) and Yale 
School of Medicine build-
ings between Cedar Street 
and Howard Avenue, and 
you will eventually come 
across a pair of facing dis-
play cases. They hold one of 
Yale’s most unusual collec-
tions: antique baby bottles.
   Many know of YSM’s renowned collection of medical curiosities. 
Few, however, know of a unique collection: antique baby bottles.
  By Christopher Hoffman
  A bottle  
 for baby
The 27 infant feeding 
vessels range in histori-
cal period from the first or 
second century B.C. to the 
1940s, and provide a fasci-
nating visual primer on the 
evolution of the baby bottle. 
They include a tiny two-
handled terracotta vessel 
resembling a vase discov-
ered in a Roman child’s 
tomb in southern Italy; an 
elaborately patterned blue-
and-white Staffordshire 
“submarine” bottle from 
the early- to mid-19th 
century; and a 1940s milk 
bottle-style feeder with 
a built-in thermometer. 
Other shapes include oval—
to mimic a breast—oblong, 
and pear, with a variety  
of lips, spouts, and mouths 
to facilitate feeding.
YNHH owns the col-
lection, thanks to the pas-
sion and generosity of one 
man, Howard Fink, MD. A 
retired Milford pediatri-
cian and professor at the 
School of Medicine, Fink 
spent decades collecting 
and researching the ves-
sels—most of which were 
given to him. He scoured 
old advertisements, journal 
articles, and books to learn 
their makers, ages, and 
histories. His relentless 
sleuthing paid off, yield-
ing basic information—and 
often much more—about of 
all the bottles. 
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“You suspect something, 
but you don’t really know 
until you research it,” Fink, 
who is 90 and lives in a 
senior facility in Chicago, 
Illinois, said in a recent 
phone interview. “There 
was really no organized 
place to look. They were all 
rather difficult.” 
As Fink approached 
retirement in 2000, he 
wanted to preserve all of 
his hard work and give 
back to Yale after years 
spent training young 
pediatricians. He decided 
to offer the collection 
to the hospital, which 
accepted it. “I spent so 
much wonderful time at 
the children’s hospital, I 
wanted to leave something 
to the hospital.” Fink said. 
“It gave a lot of satisfaction 
to be able to do that.”
Consulting his 
research, Fink wrote 
captions, and he and his 
wife placed the bottles in 
the display cases nearly 
20 years ago. They’ve been 
there ever since, accord-
ing to hospital archivist 
Susan Dee. In 2012, hos-
pital officials retyped the 
collection’s labels and 
installed new lights, but 
the collection is other-
wise unchanged from the 
time that Fink donated 
it, Dee said. Although the 
bottles are not in an area 
accessible to the general 
public, their location in 
spout—sticking out from 
its side. Its makers called it 
a Mammele—“little breast” 
in German, according to 
Fink’s research.
Not all the bottles have 
happy stories. The display 
includes several so-called 
“murder bottles”—a style 
popular in the late 19th 
and early 20th centuries 
that used a rubber hose to 
convey milk from the ves-
sel to the baby. The rubber 
hoses proved impossible 
to sterilize completely, 
leading to infections that 
killed many infants. In 
spite of moves to ban the 
bottles as early as 1897, 
a high-traffic hallway of 
the Clinic Building means 
they get a lot of passersby, 
Dee said. “It’s kind of a 
landmark,” she said in a 
recent interview. “People 
know them.”
Fink, a New York 
City native who attended 
medical school at the 
University of Louisville, 
moved to Milford in 1959 
and established a pedi-
atrics practice. One day, 
a nurse told Fink she’d 
found some old baby bot-
tles in her attic and asked 
him if he wanted them. 
He said yes and quickly 
became an avid collector. 
“I was always a real hobby-
ist, and this was my favor-
ite hobby,” he said. 
Why the fascination? 
Professional curiosity, 
Fink replied. “So much 
of a pediatrician’s time is 
spent advising mothers on 
how to feed babies, how to 
prepare formula, how to 
nurse,” he said. “So any 
pediatrician would natu-
rally be interested in some-
thing like this.”
Other highlights of 
Fink’s collection are a 
lantern-shaped vessel with 
a spout that dates from A.D. 
second- or third-century 
Israel, and a circa 1774 tin 
feeder forged by German 
craftsmen in Pennsylvania. 
It resembles a tiny pitcher 
with a rod topped by a tiny 
ball on the end—the feeding 
they remained for sale in 
the Sears, Roebuck & Co. 
catalog—the mail-order 
Amazon of its day—as 
late as 1915, according to 
Fink’s research. 
Dee said the school 
greatly appreciates the col-
lection, adding she wishes 
she knew even more about 
it. “To have it right here 
on our property on the 
hospital grounds is pretty 
unique,” she said. “I know 
it gets seen.” That’s music 
to Fink’s ears. Decades later, 
he remains happy that he 
gave YNHH the bottles he 
painstakingly collected and 
researched.
“It gave me a lot of 
pleasure,” Fink said. “All 
my work hasn’t been 
wasted. Someone else is 
enjoying them.”
Among the notewor-
thy collections at Yale 
is Yale New Haven 
Hospital’s collection 
of baby bottles, which 
includes extraordi-
nary examples from 
across a broad scope 
of cultures and human 
history dating back 
to ancient Rome. As 
is often the case, the 
collection was the 
result of one doctor’s 






















  Learning across  
 boundaries to  
   end preventable  
  maternal deaths 
»
every two minutes, a woman dies from pregnancy-  
or childbirth-related complications. Mary-Ann Etiebet, 
MD/MBA ’03, wants to change that. In 2016, Etiebet joined 
Merck to be the executive director of Merck for Mothers,  
a global initiative focused on ending preventable maternal 
deaths. She uses her background in medicine and business 
to advance innovative multisectoral approaches to reducing 
maternal mortality around the world.
program. She realized that to 
effect the kind of institutional 
changes and sustainable health 
care outcomes she envisioned, 
she would need to understand 
medicine, society, business, and 
policy—and that Yale was the 
perfect place to do all of that.
“The whole ethos of the Univer- 
sity, and the cross-disciplinary 
learning that happens between 
the schools and the departments, 
meant there was enough flex-
ibility in the curriculum to be 
able to prepare myself for those 
non-traditional paths,” she said.
After graduation Etiebet 
completed her internal medicine 
residency at Cornell, infectious 
disease fellowship at Columbia, 
and then joined the faculty at 
the University of Maryland, 
where she worked on their 
PEPFAR HIV/AIDS program 
in Nigeria. During her time 
there, she contributed to health 
care policy and health system-
strengthening efforts, and saw 
firsthand the positive effects of 
integrating the clinical public 
health and public policy arenas. 
Merck for Mothers offered 
Etiebet the perfect opportu-
nity to put to use skills she 
had accrued over the years. “It 
brought together my interna-
tional experience, my U.S.-
based experience, and the 
research I’d done,” she said. 
“More importantly, it allowed me 
to think about how to harness 
the role of the private sector to 
advance innovation and bring 
diverse stakeholders to this 
issue—space.”
Etiebet, who grew up in Nigeria, 
always knew she was going to 
become involved in health care—
she just didn’t know how. She 
decided to pursue medicine when 
on a drive to school one day, she 
spotted a teenage girl with rick-
ets walking down the road with 
her younger brother. The brother 
wore a school uniform, but the 
young girl did not, and could no 
longer pursue her education.
“I realized that without good 
health you couldn’t realize your 
full potential, or completely have 
economic independence,” Etiebet 
said. “Even now, that moment is a 
reminder that we cannot separate 
the effects of health from broader 
societal opportunities.”
Etiebet pursued her higher 
education in the United States, 
studying political science as an 
undergraduate at Yale before 
continuing on to the MD/MBA 
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In her role at Merck for 
Mothers, Mary-Ann 
Etiebet leads active 
projects in 48 countries  
to help reduce the rate 
of preventable mater-
nal deaths.
voices into those committees, to 
make sure health care provid-
ers understand what happens to 
women before they walk into a 
hospital to deliver.
“To reduce preventable mater-
nal deaths, health equity needs to 
be put front and center, and we 
believe that all the solutions that 
are developed and implemented 
should not just be informed by, 
but led by the women that are 
impacted,” Etiebet said. At the 
international level, Etiebet and 
At Merck, Etiebet manages a 
core team of 12 people, access to 
experts across the Merck enter-
prise with whom she can con-
sult with for different projects. 
Merck for Mothers currently has 
active projects in 48 countries, 
with a focus on four countries 
with high rates of preventable 
maternal deaths: Nigeria, India, 
Kenya, and the United States.
It often surprises people that 
maternal mortality is on the rise 
in the U.S., Etiebet said, particu-
larly since global rates are declin-
ing. For many years, the U.S. did 
not closely track its number of 
preventable deaths, and thus 
researchers did not understand 
why women were dying during  
pregnancy and childbirth. Data 
collected by the CDC through the 
support of Merck for Mothers 
found that over 60% of maternal 
deaths for American women  
are preventable.
“Once data became available, 
we saw that our rates are actually 
getting worse, not better, and 
we’re seeing increased dispari-
ties between Black and White 
women,” Etiebet said. 
Black women are, on aver-
age, three to four times more 
likely to die from maternal com-
plications than White women. 
Maternal mortality rates high-
light some of the institution-
alized inequities in the U.S., 
Etiebet said. 
That’s why in 2018, Merck 
for Mothers launched the Safer 
Childbirth Cities Initiative, 
which aims to support com-
munity-based organizations in 
cities across the U.S. with a high 
burden of maternal mortality 
and morbidity by implementing 
local solutions that bridge the 
gap between clinic and commu-
nity, which helps cities become 
safer—and more equitable—
places to give birth. 
Additionally, by support-
ing organizations like the CDC 
and the Association of Maternal 
& Child Health Programs 
(AMCHP), Merck for Mothers 
has helped increase the number 
of states with official maternal 
death review committees to 
more than 40. And most impor-
tantly, Etiebet said, these states 
































Ilkay Alp Yıldırım, PhD, 
an associate profes-
sor of pharmacology 
at Istanbul University, 
learned many key prac-
tices and research hab-
its during a postgradu-
ate fellowship at Yale 
School of Medicine.
For more on Yıldırım, visit 
ymm.yale.edu/pharma
her team work to make sure that 
the interventions they bring to 
different countries are sustainable.
“We think about the local 
ecosystem, and who will con-
tinue to champion and invest in 
this work,” Etiebet said. “We 
ask, ‘How can we use the local 
private sector to continue to 
advance progress?’ ”
A good example is a platform 
called Together for Her Health, 
which creates an online rating 
system for women in communities 
in India to review their maternal 
health care providers. The system 
not only informs other women 
about the best clinics to seek for 
different services, Etiebet said, it 
also creates an incentive for other 
facilities to improve their offerings 
so that they don’t lose patients.
“Sustainability is enabled 
when we create value,” Etiebet 
said. “If we listen to and value 
women and their experiences, 




Bringing it full circle
The UCLA School of Law fac-
ulty biography page for Julie D. 
Cantor, JD, MD ’05, describes 
her as “a national expert on 
issues that fall at the intersec-
tion of medicine and law.” It’s 
clear that Cantor, as a profes-
sor, attorney, physician, artist, 
entrepreneur, and mother, oper-
ates at many intersections. 
Her rich diversity of pas-
sions and interests began in 
childhood. “I came from a fam-
ily that valued both education 
and entrepreneurship,” Cantor 
said. “And always trying to 
contribute in a unique and nec-
essary way.” Even at a young 
age, she understood the need 
for social justice and advocacy. 
When a busy street near her 
childhood home needed a cross-
ing guard, Cantor said, “I was 
so incensed about that problem 
that as a 6-year-old, I wrote a 
letter to the editor of the local 
newspaper about it.” 
Cantor was raised on action. 
In the 1970s, her father, a chil-
dren’s dentist and artist, and her 
mother, a kindergarten teacher, 
created a space-themed chil-
dren’s dental practice. It was 
complete with spaceship decor 
and pilot uniforms. “I think they 
had an innate sense that what it 
takes to succeed in this culture is 
to do something that’s different, 
that’s creative,” Cantor said.
She quickly discovered both 
aptitude and enthusiasm for 
school, which eventually led to 
Stanford University. Majoring 
in psychology, she also engaged 
with history, literature, and art 
history—and took advantage of 
an opportunity to study in Italy, 
where her mother had studied 
and where her parents honey-
mooned. The country had a last-
ing effect on Cantor. 
After completing both a 
BA and an MA in psychology, 
Cantor worked at the Program 
in Bioethics at UCSF. There, she 
worked with a physician and 
an attorney. “I liked the way 
[they] would comment on things 
that were going on in the world 
at the intersection of law and 
medicine,” she said. Her men-
tors wrote about the potential 
impact of cases pending before 
the Supreme Court of the United 
States on assisted suicide, and 
the piece was published in a 
leading medical journal. “I 
remember thinking: that’s the 
pinnacle of greatness,” Cantor 
said. “How do I get to do that?”
Cantor spent two years at the 
University of California, Berkeley, 
School of Law, then moved to Yale 
to complete a visiting year at Yale 
Law School and begin medical 
school. Yale School of Medicine 
proved an opportunity for Cantor 
to explore, refine, and coalesce 
her interests. She enjoyed writing 
and lecturing, and published her 
first article in the New England 
Journal of Medicine. Though her 
passions did not fit neatly, Cantor 
said, “I just kept pursuing things 
that were interesting to me and 
had hoped—and continue to 
hope—I can contribute to other 
people’s lives and contribute to 
the dialogue.” 
After graduating, Cantor 
accepted a position with a Los 
Angeles law firm, Munger, Tolles 
& Olson LLP. She was one of a 
handful of physicians in her Yale 
class to pursue an option other 
than residency. “It was a very 
academic firm, so I knew they 
would be okay with me want-
ing to teach and lecture,” she 
said. While juggling work as 
an adjunct professor at UCLA 
School of Law and also starting 
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a sophomore seminar; and by 
writing about issues that affect 
both of those fields. And she’s 
frequently approached with 
requests for public comment. 
Whether in the New England 
Journal of Medicine or on Good 
Morning America or somewhere 
in between, Cantor is always 
happy to speak. As she puts it, 
“it’s an opportunity to take what 
I’ve learned, including what I 
learned at Yale, and advance the 
conversation, improve lives, and 
solve problems.”
—Lauren Kay Johnson 
a family, she made a name for 
herself at the firm working on 
cases informed by her medical 
background, including a case 
challenging Kentucky’s lethal 
injection protocol, for which  
she co-authored an amicus brief 
to the U.S. Supreme Court.  
“I was really fortunate to work 
on teams with people who were 
so illustrious in their field as 
lawyers that they brought in 
these incredibly interesting 
cases,” she said.
Cantor’s next career endeavor 
grew, as always, from an eye 
attuned to progress. Working 
as a litigator and representing 
high-profile clients, she found 
herself saddled with an unwieldy 
amount of paperwork, baggage, 
and materials. “I had a rolling 
bag, a tote, plus a laptop,” she 
said. “When you add it all up 
it’s pretty heavy, and I thought 
there’s got to be a way where 
this can really have an element 
of self-expression and style, and 
also be beautifully made and 
made to last forever, and can be 
totally functional.” 
As she had when she was 6 
years old, Cantor recognized and 
addressed a need. To create a 
perfect career accessory, Cantor 
founded Harlen, a brand that 
elevates women’s work bags to 
Modern Careerpieces, a term she 
trademarked. Harkening back to 
her time—as well as her mother’s 
time—studying art history in 
Italy, the Harlen Collection is 
handcrafted in Italy. She named 
the brand for her grandparents, 
Harriet and Lenny, whom she 
credits with igniting her sense 
of style and who were also “real 
supporters of girls’ education and 
empowerment and autonomy 
and independence.” In that spirit, 
to move opportunity from suc-
cessful women to the next gen-
eration, Harlen partners with 
Room to Read, an acclaimed 
non-governmental organization 
dedicated to global literacy and 
girls’ education.
Though many things have 
come full circle for Cantor, she 
isn’t finished. In addition to 
leading Harlen, she remains 
engaged with both medicine 
and law through her UCLA 
Law seminar, “Reproductive 
Rights, Medical Ethics & the 













Yale School of 
Medicine alumna Julie 
Cantor demonstrates 
that an MD can 
lead far outside the 
physician’s field. She 
has co-authored an 
amicus brief to the Su-
preme Court, founded 
the Harlan Collection, 
and published in The 
New England Journal 
of Medicine. 
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   When the bone breaks, 
  the cradle won’t fall
medicine. She would 
always listen to everyone 
in the room, regardless of 
hierarchy. … She encour-
aged me to attend medical 
school, and was generally 
a huge advocate of women 
in medicine. Being a doc-
tor had always seemed 
impractical and then 
I worried that maybe I 
wasn’t smart enough—I’m 
old enough to remember 
being told by an elemen-
tary school teacher, “You 
don’t want to be smarter 
than the boys.” I didn’t 
personally know any doc-
tors growing up. And the 
impact of one encourag-
ing me to pursue that 
goal, acting as a mentor 
and role model—that 
was so important. The 
Perry Initiative is held in 
54 locations nationwide 
now, offering daylong 
programs for young 
women in high school 
who want to explore 
opportunities in science, 
specifically engineering 
and orthopaedic surgery. 
We also have a Medical 
School Outreach Program 
for first- and second-year 
female medical students 
to expose them to the 
specialty; as an overall 
field, the national aver-
age for women applying 
and being accepted into 
an orthopaedics program 
is 14%. For first- and 
second-year women who 
have gone through our 
program, it’s 26-30%.
Do you view your time as a 
physical therapist as a dis-
traction, then? Quite the 
contrary. I wouldn’t be 
the surgeon I am without 
that practical whole-
person approach that I 
learned as a physical ther-
apist. Surgeons can fall 
into the trap of viewing 
the body mechanistically, 
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question and answer
LISA LATTANZA, MD, credits strong mentorship and an unusual 
career path with her resounding success in the field of ortho-
paedic surgery. She’s excited to bring the lessons she’s learned 
to the Yale Department of Orthopaedics and Rehabilitation.
There are three female chairs of medical school orthopae-
dics departments in the United States. The most recent, Lisa 
Lattanza, MD, comes to Yale School of Medicine via the 
University of California San Francisco.
{ To nominate a subject for Q&A, contactYale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.
Your journey to department 
chair has been unusual. 
How did growing up lead 
you to the field of medicine? 
I come from a family of 
five kids in rural Ohio. 
My mother was a teacher 
and my dad was a school 
psychologist. I had always 
thought about a career in 
medicine but they told 
me they couldn’t afford 
medical school. A high 
school sports injury 
exposed me to orthopae-
dic surgery and physical 
therapy, and the latter 
seemed like a feasible way 
to enter the profession, 
so that’s what I studied 
in undergrad. I landed 
a job at the Kerlan-Jobe 
Orthopaedic Center in Los 
Angeles, where I treated 
patients with sports inju-
ries and did research. I 
also met a prominent 
orthopaedic surgeon, 
Jacquelin Perry, MD.
Is that the Perry of your 
Perry Initiative? That’s 
right. Perry had an enor-
mous impact on how I 
viewed the practice of 






like, a part here breaks 
and you fix it. And while 
there’s some truth to there 
being a kind of inter-
changeability of some 
parts, they all affect each 
other, and you really see 
that with certain injuries 
that cause a cascade of 
secondary and tertiary 
problems. All surgeons 
don’t need to take the 
path I did, but I appreciate 
the road I traveled.
When did you realize you 
wanted to be an orthopaedic 
surgeon specifically?  
The seed was planted at 
Kerlan-Jobe, a big sports 
medicine group that took 
care of the Lakers and 
Dodgers among other pro-
fessional athletes.  
I’d lettered in three  
sports in high school, 
played basketball, ran 
cross country in college, 
and had a passion for ath-
letic competition.  
I went back to medi-
cal school to become an 
orthopaedic surgeon.  
I initially thought during 
residency that I would 
pursue sports medicine 
specialty training but 
that changed when I did 
a couple of congenital 
hand cases with a hand 
surgeon at the children’s 
hospital in Kansas City. It 
blew my mind that you 
could take a child that 
was born without a thumb 
printing organs, using 
material grown from a 
patient’s own cells for 
transplant. What I would 
like to see happen on this 
campus is a 3D surgical 
center that’s multidis-
ciplinary. … Radiology, 
general surgery, ortho-
paedics, maxillofacial, 
plastic surgery, urology, 
whoever can benefit from 
this technology. That will 
keep Yale at the forefront 
of surgical innovation and 
treatment. 
Other plans include 
an expansion of our 
capabilities regionally 
and internationally. We 
can always add to the 
great job we’ve done sup-
porting the local com-
munity’s orthopaedic 
needs. There are also 
plans to continue build-
ing on existing global 
partnerships. Those take 
the shape of clinical 
growth, and also volun-
teer projects.
Finally, I hope to keep 
our departmental eye on 
the ball when it comes 
to diversity, equity, and 
inclusion. A lot of people 
who grew up thinking 
they couldn’t make it or 
ortho wasn’t for them 
when I was younger have 
done a good job of open-
ing locked doors. We’re 
all hoping to see the next 
generation walk through.
and make them a thumb 
from an index finger or 
toe. And, boom, their life 
was impacted forever in 
a positive way. Prior to 
that experience my dream 
job had been team physi-
cian for the Pittsburgh 
Steelers (my dad had 
grown up there), but see-
ing the impact that kind 
of surgery had versus an 
ACL reconstruction so 
that someone could go 
back to playing a sport. … 
and now I’m a hand and 
upper extremity surgeon 
treating both children and 
adults. My time at Texas 
Scottish Rite Hospital for 
Children in Dallas with 
Marybeth Ezaki, MD, and 
Peter Carter, MD, also 
helped play a role in that 
decision; I really have 
been blessed with fantas-
tic mentors.
What are your plans for the 
department, moving for-
ward? Right now, ortho-
paedic surgery benefits 
tremendously from 3D 
printing for planning—
where to cut a bone, how 
to resolve complicated 
procedures—this increases 
the effectiveness of opera-
tions and reduces error. 
In the future, though, it 
looks like we’re headed 
toward 3D-printed bio-



















  How to make the lives  
of those with dementia joyful
   By Cathy Shufro
Psychiatrist and bioethi-
cist Tia Powell, MD ’87, has 
already written her demen-
tia playlist just in case. The 
list comprises 16 songs she 
loves, beginning with “Let’s 
Groove” by Earth, Wind & 
Fire, and wrapping up with 
Otis Redding’s version of 
“Try a Little Tenderness” and 
the Billie Holiday rendition 
of “I’ll Be Seeing You.”
Those tunes could come 
in handy if Powell develops 
dementia, as even people 
who can no longer speak 
often still enjoy music. “This 
playlist helps me create 
a positive image of living 
with dementia,” said Powell, 
who directs the Montefiore 
Einstein Center for Bioethics 
and holds the Shoshanah 
Trachtenberg Frackman 
Chair in Bioethics at Albert 
Einstein College of Medicine. 
In Dementia Reimagined: 
Building a Life of Joy and 
Dignity from Beginning to 
End, Powell explores how 
technology, intergenerational 
symbiosis, and shifts in 
values can make the lives of 
those affected not only more 
tolerable but even joyful. 
Powell reminds readers that 
the burden of Alzheimer’s 
and other forms of dementia 
will only worsen as she and 
her fellow baby boomers 
grow older. Dementia affects 
roughly four out of 10 people 
who reach age 85. However, 
she writes, “This illness is not 
just about loss; it is also about 
preservation—of affection, of 
dignity, of hope.” 
Powell fears that no pill  
will arrive to save her gener-
ation; present experimental 
drugs for Alzheimer’s, for 
instance, have a 99.6% failure 
rate. “Science plays the long 
game,” she said. And so while 
scientists work toward a cure, 
Powell recommends that we 
also invest in care. “If we 
focused more on the reality of 
care and less on the fantasy 
of eradication, we might deal 
with these pressing issues.” 
For physicians, this 
approach will require a cul-
tural shift. Medicine “sees 
itself as manly, offering 
heroic cures,” Powell wrote. 
“But a great deal of what 
medicine offers patients is 
care—incremental, accom-
modating, feminine (if you 
stick with the outmoded 
metaphor). Yet medicine is 
embarrassed to admit this. 
Care seems soft and unscien-
tific; we’d prefer to hand out 
[a] swashbuckling cure.”
She said physicians can 
improve care by looking 
beyond the immediate effects 
of a potential treatment or 
test. For instance, perhaps the 
$2,500 for a PET scan would be 
better spent helping a patient 
arrange help with meals 
(nutrition) or avoid isolation 
by joining a singing group 
(possibly improving mood 
and mental status). To add this 
layer of care, medical practices 
could employ a social worker 
or treatment coordinator. “The 
benefit of being part of Big 
Medicine is you may be able to 
access resources that a single 
doc in a lone office is not able 
to,” Powell said. 
Powell manages to remain 
upbeat, peppering her book 
with witticisms while also 
addressing the challenges 
of dementia, from the huge 
expense (“heading like a me-
teor toward the children of 
the baby-boom generation”) 
to the nitty-gritty: adults in 
diapers, older individuals 
lost after wandering away 
from caregivers. She rejects 
the claim that the costs of 
dementia care will spark an 
intergenerational war. Older 
and younger individuals can 
benefit from working together. 
In some places in Europe,  
for example, young artists and 
musicians get free or reduced 
housing in return for helping 
older people who live along-
side them. 
Powell believes that our 
society overvalues intelligence. 
“I love to think I’m smart, but 
I’m not sure that snobbery is 
one of my best features. There 
has been some very interesting 
thinking by people in the dis-
ability rights movement about 
what defines a person, and to 
what sort of person we owe 
respect and consideration. 
“I find it very upset-
ting when people talk about 
having dementia as being 
a loss of dignity,” she said. 
Drooling and incontinence 
are “adorable in babies, and 
accepted as a natural part of 
the developmental arc.” In 
older people, “that’s just the 
body breaking down, not a 
moral failure. It’s an arc, and 

























{Send notices of new books toYale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.
book review
F ROM A DI V E R S I T Y PE R S PE C T I V E , the future is now when it comes to the student body of the 
School of Medicine. At Yale’s White Coat Ceremony on August 12, it was impossible not to witness 
progress in a class that is anything but homogeneous as members of the Class of 2023 pulled on their 
symbolic white coats.
Beyond the superficial differences among students, the class included 32 future physicians born 
in 15 countries outside the United States, and from disparate economic and academic backgrounds 
(including 29 students from groups underrepresented in medicine, or URiM, over a quarter of the 
class). Fifteen students were the first in their family to attend college. 
Emily Wang, MD, associate professor of medicine (general medicine) and director of the Health 
Justice Lab, delivered the keynote address. She instructed her audience to think about the roles they 
can play in their patients’ lives. “Starting today, your white coat gives you the privilege to bear wit-
ness to your patients’ sufferings and their strengths; to share that burden, and then to safeguard 
their human civil rights.” 
—Adrian Bonenberger
 Changing of the guard
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end note
